Keywords: |
vasculotropin; protein expression; unclassified drug; angiogenesis inhibitor; nonhuman; conference paper; genetic analysis; protein function; neoplasms; animal cell; mouse; animals; mice; mice, knockout; gene targeting; bone marrow; inhibitor of differentiation 1; embryo; protein protein interaction; neoplasm proteins; animal experiment; animal model; protein; tumor xenograft; drug design; angiogenesis; neovascularization, pathologic; vascular endothelial growth factor receptor-2; animalia; transcription factors; stem cell; tumor suppressor gene; vascular endothelium; endothelium, vascular; hematopoietic stem cells; beta galactosidase; neoplasms, experimental; models, genetic; tumor model; inhibitor of differentiation protein 1; tumor growth; dna binding; bone marrow transplantation; vascular endothelial growth factor receptor-1; tumor vascularization; repressor proteins; nervous system development; cell motility; neuroblast; phage display; knockout mouse; lethality; gelatinase a; inhibitor of differentiation 3; inhibitor of differentiation proteins; helix loop helix protein; beta3 integrin; humans; human; priority journal; protein e
|